Santiago Zelenay

9PUBLICATIONS
95CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 30, 2025
DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation.

Michael D Buck, Tomás Castro-Dopico, Oliver Schulz

|Oct 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.

Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang

|May 02, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy.

Kok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie

|Apr 25, 2024
Vitamin D regulates microbiome-dependent cancer immunity.

Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam

|Apr 20, 2022
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.

Charlotte R Bell, Victoria S Pelly, Agrin Moeini

|Feb 14, 2022
RNA sensing via the RIG-I-like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency.

Jorn E Stok, Timo Oosenbrug, Laurens R Ter Haar

Pageof 2

Frequent Collaborators

3 joint publications

Caetano Reis e Sousa

3 joint publications

Christian P Bromley

3 joint publications

Maria A Koufaki

3 joint publications

Charlotte R Bell